BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21836650)

  • 21. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen.
    Wu KC; Li HT; Qiao TD; Li CN; Ji WS; Tian FQ; Wang X; Wang BL; Miao JY; Ding J; Fan DM
    Chin J Dig Dis; 2004; 5(1):22-7. PubMed ID: 15612668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
    Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
    Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C; Vakil N; Rugge M; Gatta L; Perna F; Osborn JF; Russo VM; Tampieri A; Bernabucci V; Miglioli M; Vaira D
    Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
    Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies].
    Valle Muñoz J; Artaza Varasa T; López Pardo R; Rodríguez Merlo R; Pérez Grueso MJ; Martín Escobedo R; Alcántara Torres M; Cuena Boy R; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2007 Dec; 30(10):567-71. PubMed ID: 18028850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer.
    Wang Y; Zhu Z; Liu Z; Zhao Z; Xue X; Li X; Li P; Rong G; Ma Y
    J Int Med Res; 2020 Mar; 48(3):300060520914826. PubMed ID: 32228342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.
    Haneda M; Kato M; Ishigaki S; Suzuki M; Takahashi M; Nakagawa M; Ono S; Mori Y; Mabe K; Nakagawa S; Kudo T; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of GastroPanel for the diagnosis of atrophic gastritis.
    McNicholl AG; Forné M; Barrio J; De la Coba C; González B; Rivera R; Esteve M; Fernandez-Bañares F; Madrigal B; Gras-Miralles B; Perez-Aisa A; Viver-Pi-Sunyer JM; Bory F; Rosinach M; Loras C; Esteban C; Santolaria S; Gomollon F; Valle J; Gisbert JP;
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):941-8. PubMed ID: 25014624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
    Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
    Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of serum pepsinogen in functional dyspepsia.
    Tahara T; Shibata T; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Yamada H; Nakamura M; Arisawa T; Hirata I
    Hepatogastroenterology; 2012; 59(120):2516-22. PubMed ID: 23178618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.
    Masci E; Pellicano R; Mangiavillano B; Luigiano C; Stelitano L; Morace C; Viale E; Freschi M; Locatelli M; Ieri R; Cavallaro A; Testoni S; Testoni PA
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):79-83. PubMed ID: 24632770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.
    Yu G; Wang GX; Wang HG; Mo FF; Tang BB
    Neoplasma; 2019 Jul; 66(4):637-640. PubMed ID: 31058531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
    Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
    Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
    Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
    Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study.
    Peitz U; Wex T; Vieth M; Stolte M; Willich S; Labenz J; Jaspersen D; Lind T; Malfertheiner P
    J Gastroenterol Hepatol; 2011 Jan; 26(1):82-9. PubMed ID: 21175799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
    Gong Y; Wei W; Yuan Y
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.